Clinical Trials Directory

Trials / Terminated

TerminatedNCT03963960

Evaluation of Daily Hemodialysis With Low Dialysate Flux in Unscheduled Patients With Kidney Injury Admitted to Hemodialysis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Centre Hospitalier Departemental Vendee · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the EQUODIA study is to evaluate the hemodynamic stability of hemodialysis with low dialysate flow in patients requiring emergency hemodialysis in the context of acute kidney injury or unscheduled end-stage renal disease, not in intensive care, compared to conventional triweekly high-flow hemodialysis. Short daily hemodialysis has excellent hemodynamic tolerance, which has already been confirmed by clinical experience. This modality, commonly used in the patient's home through new machines allowing a low dialysate flow purification technique, can prove to be an innovative, effective and safe alternative for patients admitted for hemodialysis in an unscheduled situation (acute kidney injury, unscheduled end-stage renal disease not followed). Up to now, no studies have evaluated the use of short daily hemodialysis with low dialysate flow in patients with acute kidney injury or unscheduled end-stage renal disease, requiring the initiation of emergency extra-renal purification.

Conditions

Interventions

TypeNameDescription
DEVICEHemodialysis with low dialysate flowHemodialysis with low dialysate flow
DEVICEConventional triweekly high-flow hemodialysisConventional triweekly high-flow hemodialysis

Timeline

Start date
2021-05-12
Primary completion
2022-04-07
Completion
2022-04-30
First posted
2019-05-28
Last updated
2024-01-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03963960. Inclusion in this directory is not an endorsement.